Minerva Neurosciences (NERV) Tops Q3 EPS by 398c

Minerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of $2.97, $3.98 better than the analyst estimate of ($1.01).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Crude Inventory Fell 4.5M Barrels Last Week - EIA
• Delta Air Lines (DAL) call put ratio 4.3 calls to 1 put with a focus on September 4 weekly 78 calls as share price up 2.9%
• DA Davidson Reiterates Buy Rating on CrowdStrike (CRWD) Ahead of User Conference